Research

NIH Alters Grant Review Process, Focusing on Scientific Merit

October 23, 2023 - On October 19, 2023, the National Institutes of Health (NIH) announced plans to alter and simplify its grant review process, attempting to eliminate reputational bias in grant allocation. The updated strategies intend to focus predominantly on the scientific merit of the research proposal rather than the historical success of the scientists who...

Read More


More Articles

Revolutionizing Clinical Trial Data Tracking, Analysis with Technology

by Alivia Kaylor

In the realm of healthcare technology, one of the most critical and revolutionary aspects is the process of tracking and analyzing clinical trial data. Clinical trials are the backbone of medical advancements, paving the way for...

Majority of Patients Quit Weight-Loss Drugs Like Wegovy Within First Year

by Hayden Schmidt

A recent cost analysis shared with Reuters showed that only a third of patients continued to use popular glucagon-like peptide-1 (GLP-1) compounds a year after initial prescription. Healthcare costs...

Merck and Moderna Skin Cancer Vaccine Significantly Reduces Risk of Death

by Hayden Schmidt

An mRNA vaccine produced by Moderna and Merck reduced the risk of skin cancer metastasis or death by 65%, according to clinical trial results shared at the 2023 session of the American Society of...

Exploring FDA-Approved Drugs and Potential Treatment Options for ALS

by Alivia Kaylor

According to 2017 CDC data, over 31,000 people are living with amyotrophic lateral sclerosis (ALS) in the United States. In America, approximately 5,000 individuals are diagnosed with ALS annually. ALS is associated with high costs, as the...

A New Era in Medicine: The Therapeutic Promise of HMO-Based Medications

by Alivia Kaylor

Human breast milk has long been recognized as the optimal source of infant nutrition, providing essential nutrients and antibodies that promote growth and protect against infection. However, research has revealed that breast milk contains...

Pfizer Eyeing Expedited FDA Approval for RSV Vaccine

by Hayden Schmidt

On Tuesday, Pfizer announced that the FDA accepted for review its Biologics License Application (BLA) for the company’s respiratory syncytial virus (RSV) vaccine candidate RSVpreF. Depending on...

Senator Targets Amgen and Indivior Acquisitions for Antitrust Action

by Hayden Schmidt

Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...

The Fundamentals of Animal Testing in Clinical Research

by Alivia Kaylor

While several different approaches are used during clinical research, traditional biomedical research involving animal testing to develop new treatments and drugs may be a strategy of the past after the FDA Modernization Act 2.0 was signed...

J&J Ulcerative Colitis Clinical Trial Produces High Rate of Remission

by Hayden Schmidt

Johnson & Johnson announced positive results from the VEGA Phase 2 clinical trial that paired the monoclonal antibody Tremfya (guselkumab) and the immunosuppressive drug Simponi (golimumab). The...

FDA and NIH Launch Partnership for Rare Neurodegenerative Diseases

by Veronica Salib

Earlier this week, the FDA and NIH announced their launch of a public–private partnership for research on rare neurodegenerative diseases. The partnership, called the Critical Path for Rare...

Biden Administration Appoints Renee Wegrzyn as Director of the ARPA-H

by Veronica Salib

The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...

Paxlovid Advantageous for Elderly COVID-19 Patients, Ineffective in Younger Adults

by Hayden Schmidt

A study published on September 1st in the New England Journal of Medicine tracking health data from 109,254 Israeli adults found a 73% reduction in hospitalization and a 79% reduction in COVID-19...

Addressing Racial Inequities in US Cancer Clinical Trials

by Alivia Kaylor

In a recent Phesi analysis of 589,295 patients participating in 6,372 United States cancer clinical trials over the last 15 years, researchers found that 42% of the African American population and 48% of the Latin American population in...

Paxlovid Reduces Patient Hospitalization Risk by 5 Times

by Veronica Salib

A study published in Epic Research found that, after taking Paxlovid, COVID-19 patients were five times less likely to be hospitalized and ten times less likely to die. Paxlovid is “an oral...

Women Are Underrepresented in Clinical Trials, Leading to Health Inequity

by Veronica Salib

Contemporary Clinical Trials published a study by researchers at the Brigham and Women’s Hospital that shows women were underrepresented in clinical trials. This conclusion may be contributing to...

Researchers Discover Promising Compound That Kills Hard-to-Treat Cancer Cells

by Alivia Kaylor

Scientists from the University of Texas Health Science Center at San Antonio have found a new target for eradicating various hard-to-treat cancer cells in culture and animal models, which could...

Eli Lilly Invest $2.1B in Indiana Pharmaceutical Manufacturing

by Hayden Schmidt

Pharmaceutical giant, Eli Lilly, will extend its operations in Indiana, adding two additional manufacturing facilities with a $2.1 billion investment. Lilly will use the new facilities to produce...

Recent Articles